intensive acute cardiovascular diseases including heart failure, acute aortic syndrome, atrial fibrillation with acute coronary syndrome/ percutaneous coronary intervention, myocarditis, acute malignant ventricular arrhythmia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria according to definition as follows: 1.Acute heart failure: discharge diagnosed with "acute heart failure" or "acute on chronic heart failure"; 2.Myocarditis: The discharge diagnosis includes "myocarditis," "dilated cardiomyopathy," or "inflammatory cardiomyopathy"; 3.aortic syndrome: discharge diagnosed with ‘aortic dissection’; 4.atrial fibrillation with acute coronary syndrome/percutaneous coronary intervention: discharge diagnosed with "acute coronary syndrome" or "unstable angina" or "percutaneous coronary intervention" complicated with "atrial fibrillation"; 5. malignant ventricular arrhythmia: discharge diagnosed with "ventricular arrhythmia"; (2)aged>=18, all genders are included; (3) Patients have signed consent to participate this study.
Exclusion criteria
Exclusion criteria: 1.Participation in another investigational drug study; 2.participant refused to sign the consent. 3.participants who are incapacity or restricted capacity to react; 4.other conditions which researchers consider participant is not suitable for this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| all-cause mortality;Aorta-related death;Aorta-related adverse events;major adverse cardiovascular events;cardiovascular death;Recurrent malignant ventricular arrhythmia; | — |
Secondary
| Measure | Time frame |
|---|---|
| thrombosis/stroke;recurrent myocardial infarction;unplanned revascularization;major bleeding defined as BARC>= class 3;cardiovascular mortality;heart failure rehospitalization;Re-hospitalization due to cardiac event; | — |
Countries
China
Contacts
Fuwai Hospital, Chinese Academy of Medical Sciences